Wencheng Ding

3.1k total citations · 1 hit paper
55 papers, 1.2k citations indexed

About

Wencheng Ding is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Wencheng Ding has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Epidemiology. Recurrent topics in Wencheng Ding's work include Cancer-related molecular mechanisms research (11 papers), Cervical Cancer and HPV Research (11 papers) and Epigenetics and DNA Methylation (6 papers). Wencheng Ding is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Cervical Cancer and HPV Research (11 papers) and Epigenetics and DNA Methylation (6 papers). Wencheng Ding collaborates with scholars based in China, United States and Hong Kong. Wencheng Ding's co-authors include Da Zhu, Peng Wu, Zheng Hu, Xiaoli Wang, Yifan Meng, Hui Wang, Ding Ma, Lingli Gui, Kezhen Li and Qin Yu and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Wencheng Ding

51 papers receiving 1.2k citations

Hit Papers

Spatial multi-omics: deciphering technological landscape ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wencheng Ding China 16 645 271 249 204 158 55 1.2k
Peng Wu China 24 809 1.3× 386 1.4× 304 1.2× 264 1.3× 347 2.2× 97 1.7k
Kezhen Li China 22 636 1.0× 336 1.2× 228 0.9× 94 0.5× 162 1.0× 61 1.5k
Liangshun You China 19 434 0.7× 216 0.8× 103 0.4× 247 1.2× 174 1.1× 45 1.0k
Soeren Lukassen Germany 12 489 0.8× 248 0.9× 113 0.5× 762 3.7× 123 0.8× 19 1.7k
Bianca P. Hennig Germany 9 745 1.2× 185 0.7× 109 0.4× 733 3.6× 86 0.5× 10 1.8k
Orla Maguire United States 21 725 1.1× 189 0.7× 297 1.2× 41 0.2× 142 0.9× 51 1.5k
Xiangyang Lin China 17 466 0.7× 92 0.3× 256 1.0× 221 1.1× 107 0.7× 38 915
Kévin Berthenet France 12 451 0.7× 145 0.5× 94 0.4× 201 1.0× 89 0.6× 15 992
Vaishali R. Moulton United States 23 592 0.9× 320 1.2× 147 0.6× 427 2.1× 130 0.8× 37 2.5k
Patricia Guevara‐Ramírez Ecuador 22 409 0.6× 243 0.9× 209 0.8× 75 0.4× 214 1.4× 83 1.5k

Countries citing papers authored by Wencheng Ding

Since Specialization
Citations

This map shows the geographic impact of Wencheng Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wencheng Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wencheng Ding more than expected).

Fields of papers citing papers by Wencheng Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wencheng Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wencheng Ding. The network helps show where Wencheng Ding may publish in the future.

Co-authorship network of co-authors of Wencheng Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Wencheng Ding. A scholar is included among the top collaborators of Wencheng Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wencheng Ding. Wencheng Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Liming, et al.. (2024). FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A‐Demethylation of PIK3R3 mRNA. Cancer Medicine. 13(24). e70507–e70507. 2 indexed citations
3.
Zhou, Xuan, Yi Jiang, Yuting Chen, et al.. (2023). The role of chemerin in the regulation of cGAS‐STING pathway in gestational diabetes mellitus placenta. The FASEB Journal. 37(3). e22806–e22806. 6 indexed citations
4.
Ye, Wei, Shitong Lin, Wenhua Zhi, et al.. (2023). Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA‐mutant cervical carcinoma via the PI3K/AKT pathway. Journal of Medical Virology. 95(3). e28656–e28656. 14 indexed citations
5.
Su, Rui, Xuan Zhou, Jingyi Zhang, et al.. (2023). Long-term outcomes of offspring from multiple gestations: a two-sample Mendelian randomization study on multi-system diseases using UK Biobank and FinnGen databases. Journal of Translational Medicine. 21(1). 608–608. 4 indexed citations
6.
Lin, Shitong, Binghan Liu, Lingling Zheng, et al.. (2023). A novel cuproptosis-related gene signature for overall survival prediction in uterine corpus endometrial carcinoma (UCEC). Heliyon. 9(4). e14613–e14613. 4 indexed citations
7.
Wei, Lijie, Jingyi Zhang, Xuan Zhou, et al.. (2023). Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM. 5(4). 100878–100878. 14 indexed citations
8.
Lin, Shitong, Canhui Cao, Binghan Liu, et al.. (2023). Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. EBioMedicine. 97. 104846–104846. 22 indexed citations
9.
Jiang, Yi, Lijie Wei, Jingyi Zhang, et al.. (2023). DHA supplementation and pregnancy complications. Journal of Translational Medicine. 21(1). 394–394. 15 indexed citations
10.
11.
Peng, Ting, Binghan Liu, Shitong Lin, et al.. (2022). APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma. Heliyon. 8(12). e12191–e12191. 4 indexed citations
12.
Xiong, Jinfeng, Jing Cheng, Hui Shen, et al.. (2021). Detection of HPV and Human Chromosome Sites by Dual-Color Fluorescence In Situ Hybridization Reveals Recurrent HPV Integration Sites and Heterogeneity in Cervical Cancer. Frontiers in Oncology. 11. 734758–734758. 10 indexed citations
13.
Gao, Peipei, Ting Peng, Shitong Lin, et al.. (2021). Key Role of MCUR1 in Malignant Progression of Breast Cancer. OncoTargets and Therapy. Volume 14. 4163–4175. 5 indexed citations
14.
Yu, Ruidi, Jun Yang, Wencheng Ding, et al.. (2020). Efficiency and safety evaluation of prophylaxes for venous thrombosis after gynecological surgery. Medicine. 99(25). e20928–e20928. 11 indexed citations
15.
Li, Xiaomin, Lu Mao, Jinfeng Xiong, et al.. (2019). An effective and biocompatible polyethylenimine based vaginal suppository for gene delivery. Nanomedicine Nanotechnology Biology and Medicine. 20. 101994–101994. 9 indexed citations
16.
Ding, Wencheng, et al.. (2018). Realgar, a traditional Chinese medicine, induces apoptosis of HPV16-positive cervical cells through a HPV16 E7-related pathway. Drug Design Development and Therapy. Volume 12. 3459–3469. 18 indexed citations
17.
Liu, Dan, Li Li, Xiaoxue Zhang, et al.. (2014). SIX1 Promotes Tumor Lymphangiogenesis by Coordinating TGFβ Signals That Increase Expression of VEGF-C. Cancer Research. 74(19). 5597–5607. 75 indexed citations
18.
Ding, Wencheng, Zheng Hu, Da Zhu, et al.. (2014). Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16/18-Positive Cervical Cancer Cells. Clinical Cancer Research. 20(24). 6495–6503. 45 indexed citations
19.
Ji, Teng, Danni Gong, Zhiqiang Han, et al.. (2013). Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer. Cancer Letters. 341(2). 231–239. 64 indexed citations
20.
Tian, Yuan, Wencheng Ding, Yingying Wang, et al.. (2013). Ubiquitin B in Cervical Cancer: Critical for the Maintenance of Cancer Stem-Like Cell Characters. PLoS ONE. 8(12). e84457–e84457. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026